Guggenheim Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Guggenheim Capital’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,354	Closed	-$1.01M	–	2108
2022 Q2	$1.01M	Buy	+18,354	New	+$963K	0.01%	1214
2018 Q2	–	Sell	-358	Closed	-$30K	–	2686
2018 Q1	$30K	Buy	358 +25	+8%	+$2.83K	﹤0.01%	2728
2017 Q4	$50K	Sell	333 -42	-11%	-$4.04K	﹤0.01%	2634
2017 Q3	$23K	Buy	+375	New	+$22K	﹤0.01%	2738

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Guggenheim Capital's SRRA Position: Q3 2022 in Review

Guggenheim Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 18,354 shares — an estimated $1.01M sold.

Guggenheim Capital first reported a position in SRRA in Q3 2017 and held it in 4 quarters. The position peaked at $1.01M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Guggenheim Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Guggenheim Capital sold 18,354 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.01M.
Guggenheim Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Guggenheim Capital's Sierra Oncology, Inc. Common Stock position peaked at $1.01M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.